Cours Luye Pharma Group Ltd Singapore S.E.
Actions
LUYE
BMG5722Z1014
Produits pharmaceutiques
CA 2023 | 6,14 Md 849 M 1,15 Md 768 M | CA 2024 * | 6,79 Md 938 M 1,27 Md 849 M | Capitalisation | 10,52 Md 1,45 Md 1,96 Md 1,32 Md |
---|---|---|---|---|---|
Résultat net 2023 | 533 M 73,62 M 99,4 M 66,64 M | Résultat net 2024 * | 658 M 90,89 M 123 M 82,27 M | VE / CA 2023 | 2,08 x |
Dette nette 2023 * | 3,67 Md 507 M 684 M 459 M | Dette nette 2024 * | 2,95 Md 407 M 550 M 368 M | VE / CA 2024 * | 1,98 x |
PER 2023 |
23,7
x | PER 2024 * |
17,3
x | Employés | - |
Rendement 2023 * |
-
| Rendement 2024 * |
-
| Flottant | 51,84% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 02/07/03 |
Rong Bing Yang
PSD | President | 58 | 08/06/94 |
Yun Li Xue
PRN | Corporate Officer/Principal | 60 | 08/06/94 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Hui Xian Yuan
BRD | Director/Board Member | 65 | 08/06/94 |
Rong Bing Yang
PSD | President | 58 | 08/06/94 |
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 02/07/03 |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,08% | 662 Md | |
+21,85% | 546 Md | |
-4,77% | 359 Md | |
+16,97% | 323 Md | |
+5,69% | 290 Md | |
+13,68% | 234 Md | |
+3,65% | 198 Md | |
-11,12% | 194 Md | |
+8,08% | 167 Md |